A pH and Light Dual-Responsive Spiropyran-Peptide Self-Assembly for Controlled Mitochondria and Nucleus Targeting
Source abstract
Abstract
Subcellular targeting represents a highly attractive approach to the development of innovative nanomedicines. Herein, we present a peptide-spiropyran conjugate system that is responsive to both pH and light stimuli. Peptides 1 – 4 self-assemble in solution and undergo a morphological transition from nanofibers to nanoparticles upon pH or light stimulation. The assembly state exerts a profound influence on their targeting properties: while the nanofiber assemblies predominantly localize to mitochondria, the nanoparticle assemblies enable translocation to the cell nucleus. Furthermore, the gemcitabine conjugate ( 1-Gem ) exhibits potent cytotoxicity against tumor cells, surpassing the efficacy of free gemcitabine by more than 10-fold. 1-Gem is capable of forming coacervates in solution, which can encapsulate additional chemotherapeutic agents. Notably, the combination of 1-Gem and doxorubicin achieves remarkable antitumor activity in the picomolar range. Thus, this work establishes a novel platform for enabling controlled organelle targeting with broad implications for the development of subcellular-targeted therapeutic strategies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photochromic and Fluorescence Chemistry · Photoreceptor and optogenetics research · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry and Materials Science
Shanghai Normal University
Institute of Chemical Biology
Shenzhen Bay Laboratory
Funding
Shenzhen Bay Laboratory · Natural Science Foundation of Guangdong Province · Shenzhen Science and Technology Program
References (48)
Show source-provided references
1. 10.1016/j.addr.2024.11538710.1016/j.addr.2024.115387 ↗
2. 10.1002/adma.20230509510.1002/adma.202305095 ↗
3. 10.1126/science.110434310.1126/science.1104343 ↗
4. 10.1038/nrc336510.1038/nrc3365 ↗
5. 10.3390/cancers1322586010.3390/cancers13225860 ↗
6. 10.1038/s41392-022-01243-010.1038/s41392-022-01243-0 ↗
7. 10.1021/acsbiomaterials.8b0161510.1021/acsbiomaterials.8b01615 ↗
8. 10.1016/j.heliyon.2024.e2600910.1016/j.heliyon.2024.e26009 ↗
9. 10.3390/medicina5711120910.3390/medicina57111209 ↗
10. 10.1002/anie.20191582610.1002/anie.201915826 ↗
11. 10.1074/jbc.RA119.01209410.1074/jbc.RA119.012094 ↗
12. 10.1021/bc200547210.1021/bc2005472 ↗
13. 10.1016/j.addr.2024.11535410.1016/j.addr.2024.115354 ↗
14. 10.1021/acs.bioconjchem.8b0077810.1021/acs.bioconjchem.8b00778 ↗
15. 10.1002/adhm.20200121110.1002/adhm.202001211 ↗
16. 10.1002/anie.20211426710.1002/anie.202114267 ↗
17. 10.1021/acs.bioconjchem.7b0079810.1021/acs.bioconjchem.7b00798 ↗
18. 10.3390/molecules2719655710.3390/molecules27196557 ↗
19. 10.1021/acs.chemrev.1c0008910.1021/acs.chemrev.1c00089 ↗
20. 10.1021/acs.chemrev.0c0030610.1021/acs.chemrev.0c00306 ↗
21. 10.1021/acs.bioconjchem.0c0002510.1021/acs.bioconjchem.0c00025 ↗
22. 10.1038/s41570-022-00373-x10.1038/s41570-022-00373-x ↗
23. 10.1038/s41570-020-0215-y10.1038/s41570-020-0215-y ↗
24. 10.1039/C5CS00889A10.1039/C5CS00889A ↗
25. 10.1021/acs.accounts.3c0059210.1021/acs.accounts.3c00592 ↗
26. 10.1063/5.017917110.1063/5.0179171 ↗
27. 10.1039/C3CS60181A10.1039/C3CS60181A ↗
28. 10.1002/anie.20060427810.1002/anie.200604278 ↗
29. 10.1002/agt2.15910.1002/agt2.159 ↗
30. 10.1039/C5NR04665C10.1039/C5NR04665C ↗
31. 10.1002/anie.20211707510.1002/anie.202117075 ↗
32. 10.1002/smll.20240899610.1002/smll.202408996 ↗
33. 10.1038/s41467-017-00047-z10.1038/s41467-017-00047-z ↗
34. 10.3389/fbioe.2021.78223410.3389/fbioe.2021.782234 ↗
35. 10.1016/j.cell.2022.05.02110.1016/j.cell.2022.05.021 ↗
36. 10.3390/v1106052410.3390/v11060524 ↗
37. 10.1038/nchem.277910.1038/nchem.2779 ↗
38. 10.1021/jacs.4c1053310.1021/jacs.4c10533 ↗
39. 10.1146/annurev-biochem-062917-01190110.1146/annurev-biochem-062917-011901 ↗
40. 10.1586/14737140.5.3.42910.1586/14737140.5.3.429 ↗
41. 10.1002/adfm.20240577310.1002/adfm.202405773 ↗
42. 10.3390/ijms2109336310.3390/ijms21093363 ↗
43. 10.3390/ijms2603137610.3390/ijms26031376 ↗
44. 10.1021/cbmi.3c0007010.1021/cbmi.3c00070 ↗
45. 10.1002/adma.20240058210.1002/adma.202400582 ↗
46. 10.1038/s41557-021-00788-x10.1038/s41557-021-00788-x ↗
47. 10.1038/s41467-023-44278-910.1038/s41467-023-44278-9 ↗
48. 10.3892/ol.2019.1062710.3892/ol.2019.10627 ↗